- Home
- ALT vs FRPH Comparison
ALT vs FRPH Comparison
Compare ALT & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALT | FRPH |
|---|---|---|
| Founded | 1997 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.5M | 435.3M |
| IPO Year | 2005 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ALT | FRPH |
|---|---|---|
| Price | $3.51 | $22.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $17.67 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 57.8K |
| Earning Date | 05-12-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.37 | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | $41,000.00 | ★ $42,846,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $136.81 |
| Revenue Growth | ★ 105.00 | 2.57 |
| 52 Week Low | $2.87 | $20.53 |
| 52 Week High | $7.73 | $28.45 |
Technical Indicators
Market Signals| Indicator | ALT | FRPH |
|---|---|---|
| Relative Strength Index (RSI) | 51.91 | 47.07 |
| Support Level | $3.40 | $21.93 |
| Resistance Level | $3.54 | $24.59 |
| Average True Range (ATR) | 0.17 | 0.55 |
| MACD | 0.07 | 0.07 |
| Stochastic Oscillator | 96.32 | 44.83 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).